Journal article icon

Journal article

Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY

Abstract:
Previous studies have demonstrated the association between antibiotic use and severe COVID-19 outcomes. This study aimed to explore detailed antibiotic exposure characteristics among COVID-19 patients. Using the OpenSAFELY platform, which integrates extensive health data and covers 40% of the population in England, the study analysed 3.16 million COVID-19 patients with at least two prior antibiotic prescriptions. These patients were compared to up to six matched controls without hospitalisation records. A machine learning model categorised patients into ten groups based on their antibiotic exposure history over the three years before their COVID-19 diagnosis. The study found that for COVID-19 patients, the total number of prior antibiotic prescriptions, diversity of antibiotic types, broad-spectrum antibiotic prescriptions, time between first and last antibiotics, and recent antibiotic use were associated with an increased risk of severe COVID-19 outcomes. Patients in the highest decile of antibiotic exposure had an adjusted odds ratio of 4.8 for severe outcomes compared to those in the lowest decile. These findings suggest a potential link between extensive antibiotic use and the risk of severe COVID-19. This highlights the need for more judicious antibiotic prescribing in primary care, primarily for patients with higher risks of infection-related complications, which may better offset the potential adverse effects of repeated antibiotic use.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3390/antibiotics13060566

Authors


More by this author
Role:
Author
ORCID:
0000-0001-5880-4827
More by this author
Role:
Author
ORCID:
0000-0001-8117-9193
More by this author
Role:
Author
ORCID:
0000-0002-3448-6702
More by this author
Role:
Author
ORCID:
0000-0002-1661-4475
More by this author
Role:
Author
ORCID:
0000-0002-2958-915X


More from this funder
Funder identifier:
https://ror.org/03x94j517
More from this funder
Funder identifier:
https://ror.org/00xm3h672
More from this funder
Funder identifier:
https://ror.org/0187kwz08


Publisher:
MDPI
Journal:
Antibiotics More from this journal
Volume:
13
Issue:
6
Article number:
566
Publication date:
2024-06-18
Acceptance date:
2024-06-11
DOI:
EISSN:
2079-6382
ISSN:
2079-6382


Language:
English
Keywords:
Pubs id:
2009681
Local pid:
pubs:2009681
Source identifiers:
2100287
Deposit date:
2024-07-10

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP